Medimaps Group

Developing deep-tech and AI imaging applications that leverage Trabecular Bone Score for advanced osteoporotic fracture risk prediction.

06/01/2026

Don’t let what’s beneath the surface go undetected.

TBS Osteo reveals the trabecular bone microarchitecture BMD misses—reclassifying up to 30% of patients into higher risk categories.¹

As pressure grows for more value per scan, radiologists and DXA techs using BMD-only reporting can underestimate fracture risk and leave referring physicians without full risk stratification.

TBS Osteo integrates directly into your workflow with individualized tissue-thickness adjustment, enterprise cybersecurity, and network-wide unified reporting—no added time or radiation.

Consistency across every site. Confidence in every scan.

See the full picture with TBS Osteo: https://www.medimaps.ai/solutions/tbs-osteo-campaign-social-media/?utm_source=social&utm_medium=social&utm_campaign=TBS_Osteo_Campaign_2026&utm_content=Post_3

¹ Hans D, Goertzen AL, Krieg MA, Leslie WD. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res. 2011;26(11):2762-2769. doi:10.1002/jbmr.499

$Beneath the surface, trabecular bone microarchitecture drives fracture risk.TBS Osteo exposes what BMD can miss—reclassi...$

05/26/2026

Beneath the surface, trabecular bone microarchitecture drives fracture risk.

TBS Osteo exposes what BMD can miss—reclassifying up to 30% of patients into higher risk categories with bone microarchitecture assessment. ¹

Leading radiologists and DXA techs know BMD-only reports can fall short, creating pressure to deliver stronger risk stratification, all while navigating everyday challenges such as variable body types and inconsistent IT security demands.

TBS Osteo solves this with seamless workflow integration, individualized tissue thickness adjustment for greater accuracy, enterprise-grade cybersecurity, and unified reporting across all systems. No additional scan time required.

Deliver high-value reports. Strengthen your role in fracture prevention.

Explore TBS Osteo: https://medimaps.pulse.ly/pzqabtacyz
Understand TBS: https://medimaps.pulse.ly/ryhk6kzdas

¹ Hans D, Goertzen AL, Krieg MA, Leslie WD. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res. 2011;26(11):2762-2769. doi:10.1002/jbmr.499

04/21/2026

It’s a wrap at 𝐖𝐂𝐎-𝐈𝐎𝐅-𝐄𝐒𝐂𝐄𝐎 𝟐𝟎𝟐𝟔 in Prague 🎉

With over 8,000 attendees, the event once again brought together a global community committed to advancing bone health and improving patient outcomes.

We were delighted to reconnect with our longstanding partners from Germany, Japan, Portugal, Slovakia, the US, and the UK, and to share the latest progress in our innovations.

A big thank you to all our partners, distributors, delegates, and friends who visited the Medimaps booth. It was a pleasure exchanging ideas and exploring how our expanded portfolio across X-ray and DXA supports both fracture detection and fracture risk prediction.

𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐀𝐧𝐧𝐚 𝐖𝐚𝐥𝐬𝐭𝐫𝐚 𝐚𝐧𝐝 𝐆𝐮𝐢𝐥𝐥𝐚𝐮𝐦𝐞 𝐆𝐚𝐭𝐢𝐧𝐞𝐚𝐮 𝐟𝐨𝐫 𝐫𝐞𝐜𝐞𝐢𝐯𝐢𝐧𝐠 𝐚 𝐘𝐨𝐮𝐧𝐠 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫 𝐀𝐰𝐚𝐫𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐨𝐮𝐭𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐰𝐨𝐫𝐤.

We look forward to seeing you again next year!

👉visit our website to learn more about our innovations: www.medimaps.ai

04/15/2026

Medimaps is proud to be exhibiting at and excited to see more than 60 posters featuring TBS!

Here’s a taste of some of the work presented 👇
https://medimaps.pulse.ly/duina6m8xi

$📢 Medimaps research selected for presentation at Congress. "Prediction of incident fractures using the AI-based TBS Re...$

04/14/2026

📢 Medimaps research selected for presentation at Congress.

"Prediction of incident fractures using the AI-based TBS Reveal* Bone Fragility Index: a Bayesian survival analysis"

Led by Gatineau, Data & AI Scientist at Medimaps, this study pushes the boundaries of fracture risk prediction by combining AI innovation with advanced Bayesian methodology.

Proud to be contributing to the science that shapes patient outcomes worldwide.

📍 WCO, OC26
📅 Saturday, April 18
🕙 11:35 AM

👉Want to know more? Schedule a meeting with our Team: https://medimaps.pulse.ly/xdttxs4gk1

* Product under development

04/08/2026

Advanced Bone Assessment to more patients: Secure, Fast & Efficient

🔍 Additional Clinical Benefits: By adjusting for tissue thickness, TBS Osteo Advanced can account for different body types, helping extend bone assessment to more patients.

🔐 Secure Connectivity: Real-time access to TBS Osteo reports across all hospital devices.

⚙️ Streamlined Operational Efficiency: Simplify DXA fleet management across your hospital.

Learn more about TBS Osteo Advanced: https://medimaps.pulse.ly/ezov1ej3od

04/05/2026

This Easter, we celebrate renewal, growth, and new beginnings 🌱🌸

For Medimaps Group, this season also marks an exciting new chapter. By bringing together the expertise of 𝐌𝐞𝐝𝐢𝐦𝐚𝐩𝐬 𝐚𝐧𝐝 𝐑𝐚𝐝𝐢𝐨𝐛𝐨𝐭𝐢𝐜𝐬, we are expanding our vision and strengthening our impact, advancing bone health and empowering clinicians around the world.

Wishing you a joyful and inspiring Easter🐣!

03/31/2026

Medimaps is pleased to join the 𝐈𝐒𝐂𝐃 𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐂𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 on April 11-12, a key event bringing together experts in bone health and densitometry.

📍 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐡𝐞𝐚𝐭𝐞𝐫 𝐛𝐲 𝐌𝐞𝐝𝐢𝐦𝐚𝐩𝐬
Advancing osteoporosis management: treatment monitoring and opportunistic case-finding with trabecular bone score

🗓 April 12, 2026 | ⏰ 1:00–2:00 PM ET

🔹 Dr. Enisa Shevroja will present the Best Clinician Abstract Award-winning study: Differential effects of osteoporosis therapies on trabecular bone score: a systematic review and meta-analysis, highlighting a more comprehensive approach to osteoporosis management by combining TBS and BMD to guide treatment decisions.

🔹Univ.-Prof. Dr. Karen Hind will introduce TBS Reveal*, a software enabling AI-based bone fragility assessment from routine X-rays
Join us to explore how TBS can support more proactive and personalized osteoporosis care.

👉Unable to join? Register to receive the recording: https://bit.ly/410zQ5j

*TBS Reveal is currently pending FDA approval

03/26/2026

Medimaps is proud to support the 𝐖𝐂𝐎-𝐈𝐎𝐅-𝐄𝐒𝐂𝐎 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬, the leading European forum for education and clinical research in osteoporosis and musculoskeletal diseases. Join us at the congress to experience AI-powered solutions advancing bone health for fracture detection and risk prediction.

👉Learn more about our program: https://bit.ly/3PZSqbe
✓Visit 𝐛𝐨𝐨𝐭𝐡 #𝟐𝟏-𝟐𝟐 to speak with our experts
✓Discover our expanded portfolio across X-ray and DXA
✓ Find out about the 𝐥𝐚𝐭𝐞𝐬𝐭 𝐓𝐁𝐒 𝐝𝐚𝐭𝐚 𝐨𝐧 𝐃𝐗𝐀 𝐚𝐧𝐝/𝐨𝐫 𝐗-𝐫𝐚𝐲
✓Attend the TBS oral presentation

We look forward to connecting with the osteoporosis and MSK community in Prague and welcoming you at our booth!

03/17/2026

At ECR 2026, Medimaps hosted a workshop on TBS Reveal with Dr. Karen Hind, Univ.-Prof. and Dr. Caroline Hopkins, Snr Director Product & PMO, Medimaps Group

👉 Watch the recording here: https://medimaps.pulse.ly/zh0e0q6usj

- Learn more about TBS Reveal*, the only AI solution that delivers both bone density and microarchitectural quality—directly from standard X-rays.
- Gain insights on how radiologists can integrate bone fragility assessment into routine workflows.
- How TBS Reveal* combines deep learning and texture analysis for a more complete view of bone fragility than BMD alone.

Address

1201 North Market Street, Suite 111
Wilmington, DE
19801

Website

http://www.medimaps.ai/

Alerts

Be the first to know and let us send you an email when Medimaps Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Medimaps Group:

Shortcuts

Want your business to be the top-listed Computer & Electronics Service in Wilmington?